Baby KJ's Medical Breakthrough
Baby KJ's doctors plan to ask the FDA to approve a clinical trial for a pioneering gene editing approach this winter.
The trial would be open to patients with seven different urea cycle disorders, offering new hope for those affected.
"This is what we thought we would never get,"
Kyle Muldoon, Baby KJ's father, expressed his emotions as he watched a football game with his son, cherishing the ordinary moments they share.
A clinical trial for a new gene editing approach may bring new possibilities for Baby KJ and others with rare diseases.
Author's summary: Baby KJ's doctors to request FDA approval for gene editing trial.
More News
- Antivax misinformation preys upon vulnerable parents
- GML - GEMFIELDS GROUP LIMITED - Two Mozambique police officers killed by illegal miners at MRM - 16/10/2025
- HILL, THOMPSON: Taxpayers should know how much their municipal governments spend
- James Norton 'eyed up' for Brian Epstein role in Beatles biopics
- She died after getting mugged for her pocketbook in South Boston. Her assailant has never been caught.
- Ally vs. SoFi® [2025]: More Account Options or Higher APYs
- Takeaways: Ottawa Senators take it on the chin in 8-4 loss to Buffalo Sabres
- Interstellar Attack Slot Review & Demo | Gambling.com
- The Supreme Court Left No Doubt: It Will Gut the Voting Rights Act
- DP World takes its Clubhouse initiative to India to help grow the game